Indian Immunologicals is advancing rabies prevention with a bi-valent monoclonal antibody, aiming to reduce rabies deaths in India, which accounts...

FRIDAY, Oct. 4, 2024 -- Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission...

FRIDAY, Sept. 27, 2024 -- An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've...

Urinary tract infections (UTIs) are one of the most common infectious diseases in the U.S., affecting about 15 million women a year. They’re...

For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus...

A government of India enterprise Indian Immunologicals Ltd (IIL), is presently developing a bi-valent medlinkmonoclonal antibody/medlink of human...

CD(Suzhou) Biopharma, a rapidly advancing clinical─stage biotech company, has received clearance from the US Food and Drug Administration (FDA) for...

Radiopharm Theranostics has moved closer to securing investigational new drug approval for a cancer-fighting radio-antibody after manufacturing the...